These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 26069187)

  • 1. Immunotherapy Combo Effective in Melanoma.
    Cancer Discov; 2015 Jul; 5(7):OF1. PubMed ID: 26069187
    [No Abstract]   [Full Text] [Related]  

  • 2. [New hope in metastatic melanoma treatment?].
    Guillot B
    Ann Dermatol Venereol; 2012 Oct; 139(10):693-4. PubMed ID: 23122388
    [No Abstract]   [Full Text] [Related]  

  • 3. Dual Immunotherapies Shrink Melanomas.
    Cancer Discov; 2015 Jul; 5(7):OF9. PubMed ID: 25998399
    [No Abstract]   [Full Text] [Related]  

  • 4. Trial watch: ipilimumab success in melanoma provides boost for cancer immunotherapy.
    Nat Rev Drug Discov; 2010 Aug; 9(8):584. PubMed ID: 20671754
    [No Abstract]   [Full Text] [Related]  

  • 5. [Nivolumab for metastatic melanoma-basic knowledge and clinical data].
    Yamazaki N; Maeda Y
    Gan To Kagaku Ryoho; 2015 Apr; 42(4):434-8. PubMed ID: 26020984
    [No Abstract]   [Full Text] [Related]  

  • 6. Melanoma drug wins US approval.
    Ledford H
    Nature; 2011 Mar; 471(7340):561. PubMed ID: 21455150
    [No Abstract]   [Full Text] [Related]  

  • 7. Update on the role of ipilimumab in melanoma and first data on new combination therapies.
    Maio M; Di Giacomo AM; Robert C; Eggermont AM
    Curr Opin Oncol; 2013 Mar; 25(2):166-72. PubMed ID: 23299197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strides in melanoma announced: maximizing value comes next.
    Tuma RS
    J Natl Cancer Inst; 2011 Jul; 103(13):997-9. PubMed ID: 21693727
    [No Abstract]   [Full Text] [Related]  

  • 9. Pembrolizumab superior to ipilimumab in melanoma.
    Cancer Discov; 2015 Jun; 5(6):568. PubMed ID: 25895921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond ipilimumab: new approaches target the immunological synapse.
    Garber K
    J Natl Cancer Inst; 2011 Jul; 103(14):1079-82. PubMed ID: 21737695
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunotherapy: Combined immunotherapy--a new standard in metastatic melanoma?
    Hauschild A; Garbe C
    Nat Rev Clin Oncol; 2015 Aug; 12(8):439-40. PubMed ID: 26099985
    [No Abstract]   [Full Text] [Related]  

  • 12. Herceptin produces clinical benefit in metastatic breast cancer regardless of tumor response.
    Oncology (Williston Park); 2004 Aug; 18(9):1201. PubMed ID: 15471203
    [No Abstract]   [Full Text] [Related]  

  • 13. CTLA-4-blocking immunotherapy with ipilimumab for advanced melanoma.
    Tarhini AA; Kirkwood JM
    Oncology (Williston Park); 2010 Dec; 24(14):1302, 1304. PubMed ID: 21294474
    [No Abstract]   [Full Text] [Related]  

  • 14. In focus: bevacizumab for renal cell carcinoma.
    Clin Adv Hematol Oncol; 2005 Jan; 3(1):68-9. PubMed ID: 16166971
    [No Abstract]   [Full Text] [Related]  

  • 15. [Medical therapy of malignant melanoma].
    Mini E; Periti P
    Ann Ital Chir; 1989; 60(4):257-63. PubMed ID: 2699710
    [No Abstract]   [Full Text] [Related]  

  • 16. Malignant melanoma.
    Schwartsmann G; Parkinson DR
    Cancer Chemother Biol Response Modif; 1993; 14():577-93. PubMed ID: 8312120
    [No Abstract]   [Full Text] [Related]  

  • 17. [Major therapeutic advances in the treatment of metastatic melanoma].
    Mateus C; Robert C
    Bull Cancer; 2012 Jun; 99(6):619-25. PubMed ID: 22652330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined immunotherapy improves survival in metastatic melanoma.
    Mayor S
    BMJ; 2015 Jun; 350():h2993. PubMed ID: 26036979
    [No Abstract]   [Full Text] [Related]  

  • 19. Genentech's anticancer Mab expected by November.
    Robertson D
    Nat Biotechnol; 1998 Jul; 16(7):615. PubMed ID: 9661186
    [No Abstract]   [Full Text] [Related]  

  • 20. Nivolumab: targeting PD-1 to bolster antitumor immunity.
    Brahmer JR; Hammers H; Lipson EJ
    Future Oncol; 2015; 11(9):1307-26. PubMed ID: 25798726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.